Monopar Therapeutics Inc.MNPRNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank89
Studio
Year-over-Year Change

Return on equity

Latest
-28.32%
↑ 59% vs avg
Percentile
P89
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-69.02%
Historical baseline
PeriodValueYoY Change
2024-28.32%+81.2%
2023-150.37%-44.3%
2022-104.22%-116.9%
2021-48.06%-19.6%
2020-40.18%-20.1%
2019-33.46%+28.3%
2018-46.66%+72.9%
2017-172.10%-311.0%
2016-41.88%-67.9%
2015-24.94%-